Thomson Medical commercial chief Cassandra Loh named Singapore CEO

It will take  effect on 1 July.

Thomson Medical Group has appointed Cassandra Loh as acting CEO of its Singapore operations effective 1 July, the healthcare provider announced.

Loh, who is currently chief commercial officer of Thomson Medical Singapore, will continue in her existing role whilst taking on the additional leadership position. She will succeed Lee Suen Ming, who is stepping down after nearly three years.

The group said the appointment comes as Thomson Medical Singapore enters the next stage of its transformation following work that began in 2022.

Melvin Heng, group CEO of Thomson Medical Group, thanked Lee for his service and said Loh’s appointment will support the company’s next phase of growth.

Loh previously held roles at Intellect, Cigna Singapore, and IHH Healthcare, where she worked in strategic partnerships, corporate health solutions, hospital operations, and market expansion.

In a statement, Loh said she will work with teams and partners to strengthen execution and continue expanding services around patient and family healthcare needs.

Thomson Medical’s Singapore operations include the 187-bed Thomson Medical Centre and a network of nearly 40 specialist clinics and facilities.

The group said it continues to focus on women’s and children’s health, whilst expanding services including orthopaedics, oncology, ENT, and general surgery.